According to Hikma Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 1.92248.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.29 | 20.27% |
2022-12-31 | 1.90 | -43.18% |
2021-12-31 | 3.35 | -17.9% |
2020-12-31 | 4.08 | 17.33% |
2019-12-31 | 3.48 | 1.17% |
2018-12-31 | 3.44 | 27.21% |
2017-12-31 | 2.70 | 0.45% |
2016-12-31 | 2.69 | -60.64% |
2015-12-31 | 6.84 | 5.91% |
2014-12-31 | 6.45 | 42.43% |
2013-12-31 | 4.53 | 29.75% |
2012-12-31 | 3.49 | 25.28% |
2011-12-31 | 2.79 | -23.99% |
2010-12-31 | 3.67 | 37.93% |
2009-12-31 | 2.66 | 69.21% |
2008-12-31 | 1.57 | -68.4% |
2007-12-31 | 4.97 | 0.35% |
2006-12-31 | 4.95 | |
2005-12-31 | N/A |